CHINT Obtains HVAC Explosion-Proof AK Certification from TÜV Rheinland
On August 30, 2022, CHINT obtained the HVAC Explosion-Proof AK Certification from TÜV Rheinland, a global leading independent third-party certification authority, marking CHINT's new milestone in ESG localization and the company's upgrade of products in response to refrigerant in the heating, ventilation, and air conditioning (HVAC) industry. The certification accredits CHINT’s 12 low-voltage products in 3 series, including the contactor and the motor starter, which can be applied to different application scenarios and future trends in the HVAC industry.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220831005332/en/
CHINT Obtains HVAC Explosion-Proof AK Certification from TÜV Rheinland (Photo: Business Wire)
With the increasing awareness of environmental protection around the world, Europe is vigorously switching towards climate-friendly cooling solutions and accelerating the application of environment-friendly refrigerants, more attention has been paid to industries of HVAC, petroleum & petrochemical, coal and power. As a global smart energy solution provider, CHINT promotes the international certification of heating, ventilation, and air conditioning (HVAC) products, effectively guides the development of power products towards low-carbon goals, and helps global HVAC customers save energy and reduce carbon emissions.
Beibei Zheng, Vice President of CHINT Global, said, "CHINT’s acquisition of TÜV China's first HVAC Explosion-Proof AK Certification indicates that while our products and system solutions certainly meet international explosion-proof requirements, we also have the capability to pursue a low-carbon sustainable development.”
Guorong Sun Vice President | Industrial Services & Cybersecurity Greater China, TÜV Rheinland, said, “We are delighted to see CHINT's continuous promotion of global energy transformation and refrigerant replacement in the HVAC industry.”
The NC1 and NC8 series AC contactors certified by TÜV Rheinland are suitable for turning on and off AC motors. The NS2 series AC motor starter can be used for motor overload protection. In order to test the safety of the related HVAC equipment when refrigerant leaks, CHINT entrusted TÜV Rheinland to conduct the explosion-proof compliance tests which simulate product usage in actual scenarios.
In terms of international localization, CHINT has always cooperated with global partners. CHINT has established a cooperation partnership and maintained active interactions with TÜV Rheinland for more than ten years. At present, with its footprint expanded to Europe, America, Africa and Asia, CHINT continuously strengthens its end-to-end delivery capabilities in the overseas markets, promotes localized brand certification, and practices its customer-oriented concept with excellent pre-services through its overseas subsidiaries, overseas manufacturing centers, and overseas warehouses.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220831005332/en/
Contact information
Cora Geng
Email: gxiaol@chintglobal.com
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Armis Wins 6 Global InfoSec Awards at RSAC 2024, Named “Hot” Cybersecurity Company6.5.2024 18:10:00 CEST | Press release
Armis, the asset intelligence cybersecurity company, today announced that it has won six Global InfoSec Awards from Cyber Defense Magazine at this year’s RSA Conference. Armis received the following accolades: Armis named “Hot Cybersecurity Company” Nadir Izrael, Armis’ Co-Founder and CTO, awarded “Cutting Edge Chief Technology Officer” Armis Centrix™ won multiple awards: “Cutting Edge” platform accolade in the Cyber Exposure Management category “Best Product” for Attack Surface Management “Next Gen” product for Vulnerability Prioritization and Remediation The Armis AI-powered Asset Intelligence Engine received a “Publisher’s Choice” award in the category recognizing AI Platforms for Cybersecurity Strategy Analytics “These accolades reinforce Armis’ dedication to innovation and our commitment to helping our customers solve their biggest cybersecurity problems through one comprehensive platform,” said Yevgeny Dibrov, CEO and Co-Founder of Armis. “Armis will continue to push the boundari
Edgio Named Winner of the Coveted Global InfoSec Awards During RSA Conference 20246.5.2024 18:00:00 CEST | Press release
Edgio is proud to announce it has received the Web Application Security award from Cyber Defense Magazine (CDM), the industry’s leading electronic information security magazine. According to Verizon’s Data Breach Investigation Report (DBIR), over 60% of data breaches were attributed to web applications, underscoring the urgent need for organizations to continuously manage threat exposure across their web applications and throughout the entire DevSecOps lifecycle. Committed to addressing the complex and evolving needs of organizations, Edgio continues to innovate and expand its services with its recent launch of Attack Surface Management (ASM) - a solution designed to discover all web assets, provide full inventory of technologies, detect security exposures and manage exposure response across an organization from a centralized management interface. ASM, coupled with Edgio’s holistic web security solutions and managed security services provide the industry’s first edge-enabled continuous
NetApp Appoints Market Growth and Revenue Operations Leader, Dallas Olson to Chief Commercial Officer Role6.5.2024 17:30:00 CEST | Press release
NetApp (NASDAQ: NTAP), the intelligent data infrastructure company, today announced Dallas Olson as the company’s new Chief Commercial Officer, reporting to NetApp’s President, César Cernuda. Olson brings over 25 years of experience building high-performance teams responsible for planning, operations, enablement, engagement, and go-to-market strategies. As NetApp’s CCO, Olson will oversee sales strategy driving business growth in key areas including AI and Keystone through specialist teams, enhance market presence, optimize sales models, foster strategic partnerships, champion a customer-centric approach, and drive initiatives to maintain NetApp’s position as a market leader primed for accelerated growth. “We’re thrilled for Dallas to join NetApp at a time of momentum for the company as we empower enterprises to make their data infrastructure intelligent with unified data storage built for innovation in the era of AI," said César Cernuda, President at NetApp. “Olson's previous achievem
Nanochon closes $4M Series Seed Prime6.5.2024 17:00:00 CEST | Press release
Nanochon, a Washington, DC-based orthopedic device biotech company has raised $4 million in its series seed prime fundraising round. The round was led by The University of Virginia Licensing and Ventures Group Seed Fund, with participation from Cultivate (MD), Alumni Venture Group, and Mountain State Capital, among others. Nanochon intends to use the funds to initiate its first in human clinical trials in the US in 2024, deepen research and development efforts, expand the company’s patent profile and grow its team. “We’re thrilled to close our funding round and begin our clinical program,” says Ben Holmes, CEO and co-founder. “Securing this funding is one step closer towards achieving Nanochon’s goals of eliminating the need for knee replacements, and greatly shifting the paradigm of arthritic joint care.” Nanochon will initiate a phase I trial in the US this year for its patented knee implant Chondrograft™. The device requires only minimally invasive surgery to regrow damaged cartilag
Biocytogen Enters Into Evaluation and Potential Licensing Agreement With BioCopy For TCR-mimic Antibodies6.5.2024 16:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315), a global biotechnology company focused on the discovery of novel antibody-based therapeutics, today announced a TCR-mimic antibody evaluation and potential licensing agreement with BioCopy AG (“BioCopy”), a research-based biotechnology company headquartered in Basel, Switzerland. The agreement grants BioCopy access to fully human TCR-mimic antibodies targeting an intracellular antigen generated by Biocytogen’s proprietary RenTCR-mimicTM mice. BioCopy will conduct an evaluation and retain the option to license these antibodies for the development of novel cancer therapies. “We are glad to provide BioCopy with our TCR-mimic antibodies,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “Our in vivo matured TCR-mimic antibodies demonstrated favorable affinity and excellent specificity. Combined with BioCopy’s expertise in TCR-mimic antibody screening and engager development, we are optimistic that our collabo